UBM Medica US has announced the launch of OncoTherapyNetwork.com – a new online community and information resource for oncologists and cancer care professionals about the use of targeted therapy and immunotherapy.
With the number of newly approved and pipeline drugs rapidly growing, targeted therapies and immunotherapies are becoming the treatments of choice for more and more clinicians. Visitors to the site can keep up with new and emerging information focused specifically on advances in this treatment area.
The new OncoTherapyNetwork.com will feature blogs written by MDs for MDs about the unique challenges of employing these agents; podcasts, videos, and webinars featuring key opinion leaders best practices in these emerging therapeutic areas; highlights from key conferences; and short quizzes specific to these new agents.
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach - online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries.
